Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00985075 · ClinicalTrials.gov registry record

A Pilot Study Evaluating the Signs and Symptoms of Seasonal Allergic Rhinoconjunctivitis Following Exposure in the Allergen BioCube

A clinical trial, sponsored by ORA.

Completed
Registry status
100
Enrollment target

NCT00985075 is a clinical trial that has completed, run by ORA. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00985075 has completed, sponsored by ORA.

COMPLETED
Registry status
100 participants
Enrollment target

Study Summary

The objective of this study is to evaluate ocular and nasal signs and symptoms in patients with seasonal allergic rhinoconjunctivitis following allergen exposure in the Allergen BioCube.

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2008-12
Est. Completion 2009-07

Sponsor

ORA

19 total trials

What the Registry Record Tells You About NCT00985075

The ClinicalTrials.gov registry entry for NCT00985075 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ORA, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00985075 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00985075 about?

NCT00985075 is a clinical study titled "A Pilot Study Evaluating the Signs and Symptoms of Seasonal Allergic Rhinoconjunctivitis Following Exposure in the Allergen BioCube". The objective of this study is to evaluate ocular and nasal signs and symptoms in patients with seasonal allergic rhinoconjunctivitis following allergen exposure in the Allergen BioCube.

What is the current status of trial NCT00985075?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2008-12. Estimated completion is 2009-07.

Who is sponsoring clinical trial NCT00985075?

This trial is sponsored by ORA, which has 19 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.